# A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

> **NCT01252056** · PHASE4 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 353 (actual)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Probucol
- **DRUG:** Probucol and Cilostazol

## Key facts

- **NCT ID:** NCT01252056
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2013-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252056, "A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01252056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*